Skip to content

GENEX

by Biocomposites Ltd

510(k) K082381

GENEX is a medical device (FDA Class II; FDA product code MQV, Filler, Bone Void, Calcium Compound) made by Biocomposites Ltd, cleared under FDA 510(k) K082381 on 14 Nov 2008, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK082381 Date14 Nov 2008ClearedStatusActive

Official records

From the FDA record

Received by the FDA
19 Aug 2008
FDA decision
14 Nov 2008 (Substantially Equivalent)
FDA review time
87 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K082381 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MQV
FDA applicant
Biocomposites, Ltd.
Device class
Class II
Regulation
21 CFR Part 888.3045
Advisory committee
Orthopedic
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code MQV (Filler, Bone Void, Calcium Compound).

Other devices from Biocomposites Ltd

See all devices from Biocomposites Ltd →